about
Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study)Impact of anthropometric cut-off values in determining the prevalence of metabolic alterations.Preparing nurses to face the pandemic of diabetes mellitus: a literature review.Sibling recurrence risk ratio analysis of the metabolic syndrome and its components over time.Global metabolic consequences of the chromogranin A-null model of hypertension: transcriptomic detection, pathway identification, and experimental verification.Nutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome.Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertensionRat chromosome 8 confers protection against dyslipidemia caused by a high-fat/low-carbohydrate diet.Individual and neighborhood socioeconomic status characteristics and prevalence of metabolic syndrome: the Atherosclerosis Risk in Communities (ARIC) Study.Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes.Adiposity and fat distribution outcome measures: assessment and clinical implications.The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes.Periodontal disease and metabolic syndrome: a qualitative critical review of their associationEpidemiology and treatment of the metabolic syndrome.Is alcohol consumption a risk factor for weight gain and obesity?Report of an NIH task force on research priorities in chronic kidney disease in children.Glycated haemoglobin as a predictor for metabolic syndrome in non-diabetic Korean adults.Survey of the relationship between metabolic syndrome and myocardial infarction in hospitals of Urmia University of medical sciencesMetabolic syndrome and sleep apnea.Fructose Containing Sugars at Normal Levels of Consumption Do Not Effect Adversely Components of the Metabolic Syndrome and Risk Factors for Cardiovascular Disease.The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs.Obesity and Cardiac Function - The Role of Caloric Excess and its Reversal.Association of insulin sensitivity and glucose tolerance with the c.825C>T variant of the G protein beta-3 subunit geneDyslipidaemia as a predictor of hypertension in middle-aged men.A high oleic sunflower oil fatty acid esters of plant sterols mixed with dietary diacylglycerol reduces plasma insulin and body fat accumulation in Psammomys obesusDietary management of the metabolic syndrome - one size fits all?Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria.Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsia.Abdominal obesity and ethnic differences in diabetes awareness, treatment, and glycemic control.Renin-angiotensin-aldosterone system loci and multilocus interactions in young-onset essential hypertension.Mapping of genetic loci predisposing to hypertriglyceridaemia in the hereditary hypertriglyceridaemic rat: analysis of genetic association with related traits of the insulin resistance syndrome.K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population.Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.The role of fitness in the association between fatness and cardiometabolic risk from childhood to adolescence.Early adversity and adult health outcomes.Influence of metabolic syndrome on hypertension-related target organ damage.Statin-induced blockade of prenylation alters nucleocytoplasmic shuttling of GTP-binding proteins gamma2 and beta2 and enhances their suppressive effect on glucocorticoid receptor transcriptional activity.Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux.The metabolic syndrome among postmenopausal women in Ecuador.The FOXC2 C-512T polymorphism is associated with obesity and dyslipidemia.
P2860
Q24796775-AD6846B4-8375-4AF1-9106-1EB6B46DB0E7Q30244063-526DB14F-B22C-4937-9534-9992EED0EFC7Q30332542-54DC4A4B-FB8C-44DD-AEFC-6660AA4F239EQ33198459-42D1B348-9D57-4657-A12C-55BEFFA63363Q33675339-7ED65F6C-BAA4-424E-8FD3-0AEC8FCE8D1CQ33843310-7577F8B0-4D8F-42A1-A81C-34F8C270B774Q33942295-6AC3C29A-D9CC-4599-B2E2-DE05D88B0665Q34206069-9F512426-7281-4232-B589-662E1A52FEDFQ34357035-C2F81146-2476-4A7F-857F-38CF3E55BD43Q34569347-8A29F741-ED18-4A0F-A774-8589F8361AAFQ35006747-16F41DCE-95F5-44AC-A0EC-2EDB268CF62DQ35207618-D4FD3B0B-4C85-468E-9CEF-A0F7E9D668A3Q35446945-0D35F9C9-A45F-42B0-8B1C-886170926827Q35915241-BB63EEC7-E910-427F-9F62-B777EC3BA093Q36209107-21C3FB99-CBE6-4272-AF55-4E50E31BE0E1Q36298407-03EE7245-A18C-4B33-B9A1-790BE9693C2EQ36628644-9E844105-D36E-4823-9A1E-D00C182032EBQ36699272-300A759D-D63C-4645-8CE0-183C8126F5BFQ36766101-EB99B8F4-E3B5-49CD-B588-B7713B99F630Q36846165-DD2165C1-1D19-4F9C-BA73-B8542BDDE697Q37148732-772FB6E2-BFA2-439F-8225-8CB1F195A705Q37158641-CFDBBB2C-A987-4CF3-BD83-2F5EC3E5A57CQ37225896-AAB1D446-6DA4-4A62-A4CD-F7867834ADD5Q37291520-5A2C66DE-42F7-40F3-83B9-6A481C773246Q37402092-7F49E22B-52BB-4916-AD67-ECAB18FDB49EQ38108902-33ABD1CC-39D3-4432-8216-3A28A54A3EA1Q38302430-8B7C96FF-1ADB-4586-8285-E34476F1EB11Q40387082-400C5527-22E8-47F4-B15B-7C3DCD62CBA4Q44255059-4D9AE23B-01D9-4759-9417-4869BC1DF0C4Q44335653-02A34560-88C0-4B71-82D9-BB0517E42B19Q44398237-96439B4B-6CC6-4FBE-BA24-C6C856CDAE35Q44436451-F8F2FAE0-240E-46A9-9DF0-8A3C9A83A2DEQ45133921-EF0400D9-1B34-4870-A0FA-D319FE15288FQ45370684-336CC5D5-712E-4D58-ADEC-CA8AC756E3C9Q46087375-C37AF1EF-0E6C-401B-9AC5-C15AF536D7F0Q46504497-C732C5F9-E8F5-4707-984A-8D6AF3A310E4Q46651400-AFC76154-44D2-4620-A374-C38A5B5DDFF2Q46877809-10839A77-17EB-4A1A-973D-D4D7021A07BDQ51488582-55984CF7-2CBD-4993-94CE-68CBF5DC8A52Q53876804-40C30917-FEB0-4027-8FD0-0569B37D7FBD
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The dysmetabolic syndrome.
@ast
The dysmetabolic syndrome.
@en
The dysmetabolic syndrome.
@nl
type
label
The dysmetabolic syndrome.
@ast
The dysmetabolic syndrome.
@en
The dysmetabolic syndrome.
@nl
prefLabel
The dysmetabolic syndrome.
@ast
The dysmetabolic syndrome.
@en
The dysmetabolic syndrome.
@nl
P2860
P1476
The dysmetabolic syndrome.
@en
P2860
P304
P356
10.1046/J.1365-2796.2001.00864.X
P407
P577
2001-08-01T00:00:00Z